Study wrapper · #944

Perceived benefits of treatment for obesity with retatrutide: A qualitative study of patients in a phase 2 clinical trial.

Goetz IA, Kanu C, Hoover A, et al. Obesity pillars. 2025.

DOI: 10.1016/j.obpill.2025.100220PubMed: 41216380

Editor's note

This qualitative exit-interview study captures patient-reported experiences from a Phase 2 retatrutide trial rather than clinical efficacy outcomes. Participants described reduced appetite, portion changes, and improved well-being, though a few reported social limitations or frustration. Useful for the lived-experience angle, with the caveat that self-reported perceptions from a small sample cannot establish efficacy.

Plain-language abstract

In a qualitative study, 40 participants exiting a Phase 2 retatrutide trial described early changes in eating behavior, improved physical and emotional well-being, and progress toward weight-loss goals, with some reporting side effects or unmet expectations.

Mixed